| 025-09-09 | 厘华般份 | 603182 | 14.59 8131.52 | 557.34 | 申万宏源证券有限 公司下演静安区昌 J1-00 1/V 401 BBC 31, AA | 中信证券股份有限 公司甘肃分公司 | 190 | | --- | --- | --- | --- | --- | --- | --- | --- | | 交易日期 | 证券商稼 | 蓬券代码 | 成交价(元) 成交金额(万元) 成交量(*) 买入营业部 | | | 美出营业部 | 是否为专场 | 9月9日，嘉华股份大宗交易成交557.34万股，成交额8131.52万元，占当日总成交额的69.42%，成交价 14.59元，较市场收盘价14.59元持平。 ...

Core Insights - The city of Liaocheng is focusing on becoming a strong manufacturing and agricultural city by advancing the development of its agricultural product processing industry, which has achieved over 100 billion yuan in revenue for two consecutive years [1][3] - The local government is promoting a comprehensive upgrade of the agricultural product processing industry, emphasizing deep processing and the entire supply chain from "field to table" [1][3] Group 1: Industry Development - Liaocheng has 544 large-scale agricultural product processing enterprises, with significant players like Fengxiang Group and Jiahua Biological achieving annual output values exceeding 100 billion yuan [1][3] - The agricultural product processing industry is crucial for Liaocheng's transition from an "agricultural city" to a "strong agricultural city," with a focus on enhancing the value chain and extending the industrial chain [3][4] Group 2: Key Enterprises and Innovations - The city has 317 leading enterprises, including 8 national-level and 64 provincial-level leading enterprises, fostering a structure where chain-leading enterprises guide and support the industry [3][4] - Companies like Dong'e Ejiao and Jiahua Biological are significant players, with Jiahua processing over 30% of the national soybean protein output [3][4] Group 3: Strategic Initiatives - The local government is implementing eight key breakthrough actions to enhance the agricultural product processing industry, focusing on "supplementing, extending, and optimizing" the industrial chain [3][4] - Efforts are being made to strengthen leading enterprises' roles in market expansion, production leadership, and technological innovation, while also integrating small and micro enterprises [4]

Group 1 - The plant-based meat concept index rose by 1.67%, ranking 8th among concept sectors, with 18 stocks increasing in value [1][2] - Leading stocks in the plant-based meat sector included SuoBao Protein, LingGe Technology, and HaiXin Food, which rose by 7.15%, 6.71%, and 4.42% respectively [1][2] - The sector experienced a net inflow of 0.14 billion yuan, with nine stocks receiving net inflows, led by SuoBao Protein with a net inflow of 28.15 million yuan [2][3] Group 2 - The top net inflow ratios in the plant-based meat sector were SuoBao Protein at 8.52%, JiaHua Co. at 7.55%, and FuXiang Pharmaceutical at 7.10% [3][4] - The trading volume for SuoBao Protein was 16.09%, while other notable stocks included AnQi Yeast and FuXiang Pharmaceutical with trading volumes of 1.03% and 3.10% respectively [3][4] - Stocks that saw declines included GuoEn Co. and XueRong Biological, which fell by 3.09% and 0.83% respectively [1][4]

Group 1 - The company, Jia Hua Co., announced the listing of its first public offering of restricted shares, with a total of 71,471,328 shares set to be available for trading [2] - The shares will be available for trading starting from September 9, 2025 [2] - The method of subscription for the shares is through offline channels [2]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603182 证券简称：嘉华股份 公告编号：2025-023 山东嘉华生物科技股份有限公司首次公开发行部分限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 本次股票上市类型为首发股份；股票认购方式为网下，上市股数为71,471,328股。 本次股票上市流通总数为71,471,328股。 ● 本次股票上市流通日期为2025年9月9日。 一、本次限售股上市类型 三、本次限售股上市流通的有关承诺 根据公司《首次公开发行股票招股说明书》及2023年6月7日披露的《详式权益变动报告书》，截至本公 告日，有关股东对其持有的本次上市流通股份所做出的仍在有效期内的有关承诺具体如下： 1、公司原实际控制人吴洪祥、黄瑞华、张效伟、李广庆、贾辉、高泽林及吴洪祥近亲属吴洪力、黄瑞 华近亲属赵冬杰、赵珂欣、张效伟近亲属陈春佳承诺： 自发行人股票上市之日起三十六个月内，不转让或者委托他人管理本人直接或者间接持有的发行人公开 发行股票前已发行的股份，也不由 ...

证券代码：603182 证券简称：嘉华股份 公告编号：2025-023 山东嘉华生物科技股份有限公司 首次公开发行部分限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 本次股票上市类型为首发股份；股票认购方式为网下，上市股数为 本次股票上市流通总数为71,471,328股。 ? 本次股票上市流通日期为2025 年 9 月 9 日。 本次上市流通的股份为公司首次公开发行部分限售股，自公司首次公开发行 股票上市至今，公司未发生配股、公积金转增股本等事项，公司股本数量未发生 变化。 根据中国证券监督管理委员会（以下简称"中国证监会"）于 2022 年 8 月 15 日出具的《关于核准山东嘉华生物科技股份有限公司首次公开发行股票的批复》 （证监许可〔2022〕1830 号）核准，山东嘉华生物科技股份有限公司（以下简称 "嘉华股份"或"公司"）首次向社会公众公开发行人民币普通股（A 股）41,140,000 股，并于 2022 年 9 月 9 日在上海证券交易所上市。首次公开发行完成后，公司总 ...

重要内容提示： 本次股票上市类型为首发股份；股票认购方式为网下，上市股数为 71,471,328股。 证券代码：603182 证券简称：嘉华股份 公告编号：2025-023 山东嘉华生物科技股份有限公司 首次公开发行部分限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 本次股票上市流通总数为71,471,328股。 本次股票上市流通日期为2025 年 9 月 9 日。 一、本次限售股上市类型 根据中国证券监督管理委员会（以下简称"中国证监会"）于 2022 年 8 月 15 日出具的《关于核准山东嘉华生物科技股份有限公司首次公开发行股票的批复》 （证监许可〔2022〕1830 号）核准，山东嘉华生物科技股份有限公司（以下简称 "嘉华股份"或"公司"）首次向社会公众公开发行人民币普通股（A 股）41,140,000 股，并于 2022 年 9 月 9 日在上海证券交易所上市。首次公开发行完成后，公司总 股本增加至 164,550,000 股，其中有限售条件流通股股份数量为 123,410,000 股， 无限 ...

国泰海通证券股份有限公司 关于山东嘉华生物科技股份有限公司 首次公开发行部分限售股上市流通的核查意见 国泰海通证券股份有限公司（以下简称"保荐机构"、"国泰海通"）作为山东嘉 华生物科技股份有限公司（以下简称"嘉华股份"、"公司"）首次公开发行股票并在 主板上市及持续督导的保荐机构，根据《证券发行上市保荐业务管理办法》《上海证 券交易所上市公司自律监管指引第1号—规范运作》《上海证券交易所上市公司自律监管 指引第11号—持续督导》等相关法律法规及规范性文件的规定，对嘉华股份首次公开 发行部分限售股上市流通的事项进行了核查，核查情况如下： 一、本次限售股上市类型 三、本次限售股上市流通的有关承诺 1、公司原实际控制人吴洪祥、黄瑞华、张效伟、李广庆、贾辉、高泽林及吴洪 祥近亲属吴洪力、黄瑞华近亲属赵冬杰、赵珂欣、张效伟近亲属陈春佳承诺： "自发行人股票上市之日起三十六个月内，不转让或者委托他人管理本人直接 或者间接持有的发行人公开发行股票前已发行的股份，也不由发行人回购本人直接 或者间接持有的发行人公开发行股票前已发行的股份。因发行人进行权益分派等导 1 致本人直接持有发行人股份发生变化的，仍遵守上述规定。 所持 ...

Core Viewpoint - Jia Hua Co., Ltd. (603182.SH) announced the release of restricted shares from its initial public offering, involving a total of approximately 71.47 million shares, which accounts for 43.43% of the company's total share capital [1] Summary by Relevant Categories Shareholder Information - The restricted shares involve a total of 11 shareholders [1] - The lock-up period for these shareholders is set for 36 months from the date of the stock listing [1] Future Trading - The restricted shares will become tradable starting from September 9, 2025 [1]

Group 1 - The company Jia Hua Co., Ltd. (603182.SH) announced the release of restricted shares from its initial public offering, involving a total of approximately 71.47 million shares, which accounts for 43.43% of the company's total share capital [1] - The shareholders involved in this release consist of a total of 11 parties, and the lock-up period for these shares is set for 36 months from the date of the stock's listing [1] - The restricted shares will become tradable starting from September 9, 2025 [1]